Menu
Not yet recruiting NCT06913036

Myocene Sensivity to Cycling Intensities

No phase Interventional Fatigue Intensity

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Low-frequency fatigue - Myocene.
Who it may be relevant to
Registry conditions: Fatigue Intensity. Basic parameters: 18 years — 35 years · Male.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Center list to be confirmed — check the primary protocol.
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

Muscular Response to Short vs. Prolonged Cycling: A Crossover Trial on Low-Frequency Fatigue Sensitivity

Overview

This study aims to address this gap by assessing LFF following different efforts in cycling, aiming to identify a pattern. Also, we expect that this study helps to clarify to which efforts (prolonged vs short) are more likely to trigger substantial changes in LFF responses.

Interventions

  • Device Low-frequency fatigue - Myocene
    Low frequency fatigue will be measured using Myocene

Primary outcome measures

  • low-frequency fatigue [Time frame: Baseline, 30 minutes post, 24 hours post]

Eligibility criteria

Inclusion criteria

  • Road cyclists

Exclusion criteria

  • Injured or recently injured participants

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: Yes

Study design

Allocation
Non-randomized
Model
Crossover
Masking
Open label
Primary purpose
Diagnostic

Study locations

Center list to be confirmed — check the primary protocol.

Identifiers

NCT: NCT06913036 · Myo_sens_001

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗